HN2002000128A - AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS. - Google Patents

AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.

Info

Publication number
HN2002000128A
HN2002000128A HN2002000128A HN2002000128A HN2002000128A HN 2002000128 A HN2002000128 A HN 2002000128A HN 2002000128 A HN2002000128 A HN 2002000128A HN 2002000128 A HN2002000128 A HN 2002000128A HN 2002000128 A HN2002000128 A HN 2002000128A
Authority
HN
Honduras
Prior art keywords
combination
anticholinergic agent
agonist
airways
treatment
Prior art date
Application number
HN2002000128A
Other languages
Spanish (es)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Priority to HN2002000128A priority Critical patent/HN2002000128A/en
Publication of HN2002000128A publication Critical patent/HN2002000128A/en

Links

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA COMBINACION PARA INHALAR DE UN AGONISTA SELECTIVO DEL RECEPTOR A2A DE ADENOSINA Y UN AGENTE ANTICOLINERGICO, CON LA CONDICIÓN DE QUE EL AGENTE ANTICOLINERGICO NO SEA UNA SAL DE TIOTROPIO.THE PRESENT INVENTION REFERS TO A COMBINATION FOR INHALING A SELECTIVE AGONIST OF ADENOSINE A2A RECEPTOR AND AN ANTICHOLINERGIC AGENT, WITH THE CONDITION THAT THE ANTICHOLINERGIC AGENT IS NOT A TIOTROPE SALT.

HN2002000128A 2002-05-24 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS. HN2002000128A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000128A HN2002000128A (en) 2002-05-24 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000128A HN2002000128A (en) 2002-05-24 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.

Publications (1)

Publication Number Publication Date
HN2002000128A true HN2002000128A (en) 2002-06-04

Family

ID=53189410

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000128A HN2002000128A (en) 2002-05-24 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.

Country Status (1)

Country Link
HN (1) HN2002000128A (en)

Similar Documents

Publication Publication Date Title
CO5540324A2 (en) AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES
CR7152A (en) A PDE4 INHIBITOR AND A COMBINATION ANTI-POLINERGIC AGENT TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS.
UY28933A1 (en) COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
DOP2012000291A (en) 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH ANTI-TUMOR AGENTS FOR USE IN THE TREATMENT OF BREAST CANCER
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
BRPI0514474A (en) multiparticulate
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
DOP2012000290A (en) 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH ANTI-TUMOR AGENTS FOR USE IN THE TREATMENT OF CANCER UTERO AND CANCER DE OVARIO
HK1139863A1 (en) Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
CO5601022A2 (en) METHODS TO TREAT PATIENTS WHO ARE MOVING DISORDERS
AR065392A1 (en) METHODS FOR TREATMENT BY INHALATION OF A DISEASE OR RESPIRATORY STATE
UY30846A1 (en) OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
PA8502901A1 (en) TREATMENT OF COMBINATION WITH IL-1RA AND COMPOUNDS THAT INHIBIT THE PROCESSING AND RELEASE OF IL-1
AR061350A1 (en) EXTENDED REGIME OF PROGRESSIVE REDUCTION OF STROGENS
DOP2009000165A (en) DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES
MX2021002321A (en) Novel methods.
MX2009006574A (en) Treatment of lung cancer.
MX2021002322A (en) Novel methods.
BRPI0712561B8 (en) Use of 3-oxo-3,4-dihydro-2-pyrazinecarboxamide
GT200500315A (en) SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE
HN2002000128A (en) AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.
BRPI0415232A (en) use of hypothermic xenon to treat neonatal asphyxia
AR044675A1 (en) METHOD FOR THE TREATMENT OF SCHIZOPHRENIA IN A PATIENT WITH OVERWEIGHT
UY27566A1 (en) PHARMACEUTICAL COMBINATION
MXPA05012772A (en) Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor.